UPDATE: JP Morgan Cuts PT to $70 on Vitamin Shoppe, Maintains Overweight on Intact Thesis
JP Morgan maintained Vitamin Shoppe (NYSE: VSI) with an Overweight and lowered the price target from $73.00 to $70.00.
JP Morgan commented, "[O]rganic store growth was ratcheted back down to 8.5% from 10% only five months after being ratcheted up, and VSI cited slight slippage in its 2013 private label product acceleration (after speaking quite optimistically just a month ago). Combined with the shift in tone from ICR, we believe investors either felt misled or questioned the degree of items on management's plate. Indeed, the dramatic sell off in the stock seemed to carry some anger with it today. Realistically, we expected it to be down but not even half the 18% drop experienced following earnings."
Vitamin Shoppe closed at $51.44 on Tuesday.
Latest Ratings for VSI
|Jan 2017||Goldman Sachs||Downgrades||Neutral||Sell|
|Jan 2017||Morgan Stanley||Downgrades||Equal-Weight||Underweight|
|Nov 2016||Morgan Stanley||Downgrades||Overweight||Equal-Weight|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.